Focus
mRNA technology dangers
‘We Must Be Very Cautious With Genetic Medicines’: Dutch Molecular Biologist Warns
Research shows that mRNA vaccines can produce foreign proteins in the human body—the effects of which are ‘unpredictable.’
|
FDA’s Failure to Safeguard the Public Resulted in Irreparable Erosion of Trust
Should the FDA have eased mRNA vaccine regulations during the pandemic and what are the safety consequences of regulatory delays?
|
Pulling Back the Curtain: mRNA Lipid Nanoparticle Design Created Potential for Clotting and Triggering Immune Overdrive
We will now discuss how the LNPs are constructed and how they behave in the body.
|
Health Implications of Poor COVID-19 mRNA Testing: Miscarriage, Vision Loss, Immunotoxicity
The regulatory authorities knew about the adverse events found in animals by January 2021, but the vaccines were permitted to go forward in humans.
|
FDA Overhaul Needed for New Vaccines and mRNA Therapies
Despite lack of adequate safety testing for the first mRNA “vaccine” for humans, the FDA granted authorization and assured the public that the product was safe.
|
‘We Must Be Very Cautious With Genetic Medicines’: Dutch Molecular Biologist Warns
Research shows that mRNA vaccines can produce foreign proteins in the human body—the effects of which are ‘unpredictable.’
|
FDA’s Failure to Safeguard the Public Resulted in Irreparable Erosion of Trust
Should the FDA have eased mRNA vaccine regulations during the pandemic and what are the safety consequences of regulatory delays?
|
Pulling Back the Curtain: mRNA Lipid Nanoparticle Design Created Potential for Clotting and Triggering Immune Overdrive
We will now discuss how the LNPs are constructed and how they behave in the body.
|
Health Implications of Poor COVID-19 mRNA Testing: Miscarriage, Vision Loss, Immunotoxicity
The regulatory authorities knew about the adverse events found in animals by January 2021, but the vaccines were permitted to go forward in humans.
|
FDA Overhaul Needed for New Vaccines and mRNA Therapies
Despite lack of adequate safety testing for the first mRNA “vaccine” for humans, the FDA granted authorization and assured the public that the product was safe.
|